Sorted by: Date | Title


Antipsychotic Drug Exhibits Cancer-Fighting Properties

January 09, 2014
(News release) In a prime example of finding new uses for older drugs, studies in zebrafish show that a 50-year-old antipsychotic medication called perphenazine can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL).
Dr. Andy Hong with Researchers

Applying local knowledge

November 17, 2016
Proximity is just one factor driving the high number of collaborations between top performing institutions in the same city, Nature reports. For example, Dana-Farber/Boston Children’s Dr. Andrew Hong and researchers from nearby institutions have teamed up to grow a cell line from a rare cancer sample and learn about its potential weaknesses.
Dana-Farber/Boston Children's Buildings

Attleboro Police Make Room for a Middleborough Boy with Cancer

March 06, 2014
Six-year-old Dylan Berio’s dream came true when the Attleboro Police Department inducted him, WickedLocal reports. The Middleborough boy has been battling a brain tumor since he was 3.
DIPG graphic

Biden should take a note from the original moonshot: Focus on just one cancer

June 30, 2016
In an opinion piece for Boston Globe Media’s Stat, the author argues for focusing the cancer Moonshot on diffuse intrinsic pontine glioma or DIPG – the universally fatal pediatric brain tumor that claimed the life of original moonshot astronaut Neil Armstrong’s daughter.
Dana-Farber/Boston Children's Buildings

Billerica High Cell-out to Help Boy with Leukemia Worthy of a Standing ‘O’

April 18, 2014
Members of the Billerica High School hockey team are giving up their cell phones for 30 days to raise money in support of a teammate with leukemia being treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, the Lowell Sun reports.
Research Test Tubes

Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder

October 28, 2013
Bluebird bio Inc., a Cambridge gene therapy company, announced that the first patient has undergone infusion with its Lenti-D drug product in a stem cell transplantation designed to slow the progression of a genetic brain disorder called childhood cerebral adrenoleukodystrophy (CCALD), reports. The patient is being treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.

Boston Hospitals Pave Way for Precision Medicine

February 05, 2015
President Obama’s proposed investment in precision medicine would help clinical researchers determine which targeted therapies are most important to study in children with cancer.
Dana-Farber/Boston Children's Buildings

Cancer Can’t Stop this Dorchester Teenager

June 14, 2014
Damone Clark, who spent “too much of his 15-year-old life navigating a path around the cancer of guns and gangs that infect his Dorchester neighborhood,” is fighting a rare bone cancer, writes Boston Herald columnist Peter Gelzinis.
Map of Rwanda

Cancer Care for the Developing World

February 02, 2015
Access to life-saving advances in treating adult and childhood cancer remains elusive in low- and middle-income countries, where the majority of cancer patients reside today.

Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma

January 25, 2018
As reported in Vector, researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
Showing 11-20 of 128 items